Weight-Loss Management - Phlebotomy Blood Testing Kit

Weight Loss Management Blood Test – For Users of Mounjaro, Ozempic & Other GLP-1 Medications

GLP-1 receptor agonists like Mounjaro (tirzepatide) and Ozempic (semaglutide) have revolutionised weight-loss and diabetes management. However, these medications can impact multiple organs and metabolic processes, making regular monitoring essential for long-term safety and effectiveness.

This comprehensive blood test profile is specifically designed for individuals using medical weight-loss injections. It provides key insights into how your body is responding to treatment by assessing:

• Kidney function:

Creatinine, Urea, eGFR, Sodium – Important for detecting dehydration or reduced kidney function, which can be affected by rapid weight loss or medication side effects.

• Liver health:

ALT, AST, ALP, GGT, Total Bilirubin, Albumin, Globulin, Total Protein – These markers monitor liver enzyme levels and protein balance, especially important as GLP-1 medications are processed by the liver and can impact liver function in some individuals.

• Lipid profile (cholesterol):

Total Cholesterol, HDL, LDL, Triglycerides, HDL % – Weight-loss drugs often improve cholesterol levels, but these markers help track your cardiovascular risk as your weight changes.

• Blood sugar control:

HbA1c – This long-term marker of glucose control is essential for those using GLP-1s for prediabetes, type 2 diabetes, or weight-related insulin resistance.

• Pancreatic health:

Amylase, Lipase – Monitors enzymes that can be affected by GLP-1 medications, helping detect rare but serious side effects such as pancreatitis.

Who is this test for?

• Individuals currently using or planning to use GLP-1 weight-loss medications (e.g., Ozempic, Wegovy, Mounjaro)
• Those wishing to track treatment safety and effectiveness
• Patients advised by their GP or specialist to monitor organ function while on medication

Available on request.

Available on request.